We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 47

Provider competition matterseven for “reference pricing”

  • Baker & Hostetler LLP
  • -
  • USA
  • -
  • October 9 2014

In a recent blog post, three Federal Trade Commission (FTC) economists splashed some cold water on advocates of “reference pricing” that seem to

When does the payment of low reimbursement rates or other conduct by an insurer violate the antitrust laws?

  • Duane Morris LLP
  • -
  • USA
  • -
  • December 6 2010

Healthcare providers and insurers should be aware of a recent decision by the U.S. Court of Appeals for the Third CircuitWest Penn Allegheny Health System, Inc. v. UPMCin which the court reinstated an antitrust challenge brought by a hospital system against another hospital system and the area's largest insurer

2013 antitrust developments for insurance companies

  • DLA Piper LLP
  • -
  • USA
  • -
  • February 13 2014

Insurers and reinsurers are often involved in collective action, either in co-ventures or by government edict. At the same time, any collaboration

District Court dismisses follow-on suit challenging Blue Cross's "MFN-Plus' contracts under both per se and rule of reason standards

  • Sheppard Mullin Richter & Hampton LLP
  • -
  • USA
  • -
  • April 11 2012

The District Court for the Eastern District of Michigan recently dismissed antitrust claims brought by the City of Pontiac against Blue Cross Blue Shield of Michigan's practice of requiring hospitals to enter into "MFN-Plus" contracts, which was alleged to have significantly raised prices to Blue Cross's competitors

State AGs in the news

  • Dickstein Shapiro LLP
  • -
  • USA
  • -
  • August 28 2014

Following multiple state and federal investigations, the U.S. Department of Justice and the AGs ofCalifornia, Delaware, Illinois, Kentucky, Maryland

Department of Justice reaches settlement in first traditional Section 2 case since 1999

  • Kilpatrick Townsend & Stockton LLP
  • -
  • USA
  • -
  • March 2 2011

On February 25, 2011, the United States Department of Justice (DOJ) announced that it settled an antitrust enforcement action against United Regional Health Care System of Wichita Falls, Texas (United Regional) in which the agency alleged that United Regional had monopolized one or more markets for hospital services by entering into agreements with health insurers not to do business with United Regional's competitors

Health insurers’ motion to treble damages against pharmaceutical companies in antitrust case is granted

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • February 7 2008

On June 1, 2005, after a jury trial lasting over three weeks, a jury found for Blue Cross Blue Shield of Massachusetts (“BCBS-MA”), Blue Cross Blue Shield of Minnesota (“BCBS-MN”), Federated Mutual Insurance Company (“Federated”), and Health Care Service Corporation (“HCSC”) (collectively “Plaintiffs”) against Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc., Cambrex Corporation, and Gyma Laboratories (“Defendants”) on state law claims agreement in unreasonable restraint of trade; conspiracy in unreasonable restraint of trade; monopolization; and attempted monopolization in the Lorazepam active pharmaceutical ingredient (“API”) market, Lorazepam tablet market and in the Clorazepate API and tablet markets

House panel approves bill to end insurance antitrust protections

  • Reed Smith LLP
  • -
  • USA
  • -
  • October 30 2009

The House Judiciary Committee has passed H.R. 3596, the Health Insurance Industry Antitrust Enforcement Act of 2009

FTC bars Texas physician group from joint price negotiations

  • King & Spalding LLP
  • -
  • USA
  • -
  • May 13 2011

On May 10, the Federal Trade Commission (FTC) announced that an independent practice association representing 900 physicians in the Amarillo, Texas, area agreed to enter in to an FTC Consent Order barring it from jointly negotiating the rates it charges insurance companies

Stakes raised in Blue Cross of Michigan “most favored nation” clause antitrust dispute as Aaetna jumps in as an antitrust plaintiff

  • Williams Mullen
  • -
  • USA
  • -
  • January 3 2012

Blue Cross Blue Shield of Michigan has been in litigation with the Department of Justice Antitrust Division for more than a year over BCM’s use of “most favored nation” clauses in its contracts with health care providers